Newport has acquired Femtolasers, a leading developer and manufacturer of ultrafast laser systems used in the scientific and biomedical research fields. According to Newport, the sale will help to extend its position in the ultrafast laser field.
Developers of high precision ultrafast lasers, Femtolasers enables some of the most advanced research applications, including attosecond science to study physical, chemical and biological phenomena at the atomic and subatomic levels.
‘Femtolasers has developed some truly impressive leading-edge technology that will be invaluable as we work together to develop the next generation of ultrafast lasers,’ said David Allen, senior vice president and general manager of Newport’s Spectra-Physics Lasers Group. ‘We look forward to their contributions to our Spectra-Physics Lasers Group.’
Established in 1994, Femtolasers is headquartered in Vienna, Austria and has an installed base of more than 850 systems in 30 countries. Newport expects the company’s sales to be in the range of $8 million to $12 million in the first year, and anticipates the transaction to be accretive to its earnings.